Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IGEN keeps up Origen court battle as Roche drops suit

This article was originally published in Clinica

Executive Summary

IGEN International has said that it will maintain its Maryland court litigation against Roche Diagnostics over breaches of the licensing agreement for IGEN's proprietary Origen diagnostic detection technology. The company confirmed it was keeping up its action just as Roche agreed to dismiss its Delaware patent suit against IGEN, and agreed to reimburse IGEN's legal fees incurred in defending the suit. These amount to some $5.7 million.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts